Psychedelics & Status: How Microdosing Became a Lifestyle Trend

The latest from Vanity Fair isn’t a celebrity profile or a deep dive into political intrigue—it’s a surprisingly detailed guide to microdosing, mapping the current landscape of subtle self-optimization from psilocybin to, yes, Ozempic. The piece, which landed online this week, isn’t necessarily advocating for any of these practices, but rather observing a cultural moment where tweaking brain chemistry (and bodies) has become increasingly normalized, and increasingly stratified by socioeconomic status.

The New Status Symbols

The article breaks down the microdosing world into distinct tribes, each with its own preferred substance and aesthetic. Psilocybin, the active compound in magic mushrooms, is apparently the choice of “overextended elder millennial moms” in Northeast Los Angeles neighborhoods like Eagle Rock and Atwater Village, accessorizing their Row-via-The RealReal wardrobes with aspirations toward Chanel’s upcoming mushroom-inspired haute couture collection. LSD, meanwhile, attracts “tech bros who aspire to be creative directors” in cities like Austin, Seattle, and Toronto, favoring Lemaire or Uniqlo U. The piece doesn’t shy away from the more controversial entries, either, including a look at the use—and misuse—of Ozempic and its GLP-1 counterparts, primarily among those in Tribeca, Beachwood Canyon, and Miami Beach, and the more esoteric world of ayahuasca, favored by those who’ve “graduated from Burning Man.”

It’s a fascinating snapshot of a particular cultural moment, and one that speaks to a broader anxiety about performance and self-improvement. The article’s categorization isn’t just about the substances themselves, but about the lifestyles and aspirations they represent. It’s a world of carefully curated aesthetics, designer labels, and a constant striving for an edge, whether it’s emotional clarity, creative inspiration, or simply a smaller waistline.

Beyond the Headlines: A Look at the Substances

While the Vanity Fair piece focuses on the cultural context, it’s worth briefly revisiting the substances themselves. Psilocybin, as the article notes, is linked to emotional clarity and a heightened appreciation for everyday experiences. LSD, historically associated with the counterculture movement, is now being explored for its potential to enhance creativity and problem-solving skills. However, it’s vital to remember that nearly all hallucinogens are illegal, and researchers don’t consider any amount of use safe, according to Cleveland Clinic.

The inclusion of Ozempic is particularly striking. Originally developed as a medication for type 2 diabetes, the drug has gained popularity as a weight-loss aid, even among individuals without a medical need for it. The article points to a reduction in “food noise” as a key benefit, but also highlights the ethical concerns surrounding its use for cosmetic purposes. The piece also touches on Ketamine, noting its use in treating depression and anxiety, and Ibogaine, a more controversial substance used in some clinics to treat substance abuse, though it carries significant health risks.

The Rise of Psychedelic Research

The increased interest in these substances isn’t happening in a vacuum. There’s a growing body of research exploring the therapeutic potential of psychedelics, particularly for mental health conditions. Michael Pollan’s Netflix documentary series, “How to Change Your Mind,” released in 2022, played a significant role in bringing these conversations into the mainstream, examining the history and use of psychedelics like LSD, psilocybin, and MDMA. This research, combined with a broader cultural shift toward openness about mental health, has contributed to the normalization of microdosing and other forms of psychedelic exploration.

Dosage and Considerations

For those curious about exploring these substances, understanding dosage is crucial. Psychedelic Passage offers guidance on starting doses and how to adjust them based on desired effects, covering psilocybin, LSD, MDMA, and ketamine. However, it’s vital to approach these substances with caution and respect, and to be aware of the potential risks involved. The Vanity Fair article, while observational, implicitly acknowledges these risks by highlighting the specific anxieties and status signaling associated with each substance.

What Comes Next?

The future of microdosing and psychedelic-assisted therapy remains uncertain. As research continues and regulations evolve, we can expect to see further shifts in public perception and accessibility. The Vanity Fair piece suggests that, at least for now, these practices are largely confined to a specific demographic—those with the resources and cultural capital to navigate this complex and often controversial landscape. Whether that will change as these substances become more mainstream remains to be seen, but the article offers a compelling glimpse into the current state of play.